Frost edit · Free shipping over $70 · Cool essentials
bpc 157 colitis

bpc 157 colitis FDA Update: Is It Approved? What Crohn’s & UC Patients Need to Know DDW 2014 Presentation: 'The impact

SKU: 97009063025
4.4
USD25.36 USD46.36

Pay in 4 interest-free payments of $6.34 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

5-Amino-1MQ Key Research Facts Chemical name: 5-Amino-1-Methylquinolinium (also abbreviated as 5A-1MQ or 5MQ) Target enzyme: Nicotinamide N-Methyltransferase (NNMT) Mechanism: Competitive inhibition of NNMT reduces 1-MNA production, preserves nicotinamide for NAD+ synthesis and SAM for epigenetic methylation Selectivity: High selectivity for NNMT does not inhibit related SAM-dependent methyltransferases or NAD+ salvage pathway enzymes Membrane permeability: High passive and active transport permeability confirmed in PAMPA and Caco-2 cell assays NNMT expression: Upregulated in obese adipose tissue, multiple cancer types, and aged skeletal muscle tissue contexts of primary research interest Downstream targets: NAD+ availability, SIRT1/SIRT3 activity, SAM-dependent epigenetic methylation, lipogenesis, energy expenditure Pre-clinical models: Diet-induced obese (DIO) mice, 3T3-L1 adipocyte cell models, aged mouse skeletal muscle models, HeLa cancer cell lines In vitro cell viability: No impact on cell viability at 10 M concentration in 3T3-L1 pre-adipocytes in published toxicity profiling What Does 5-Amino-1MQ Do in Research

bpc 157 colitis FDA Update: Is It Approved? What Crohns & UC Patients Need to Know DDW 2014 Presentation: 'The impact

Invert vial and draw your dose slowly 5

bpc 157 colitis FDA Update: Is It Approved? What Crohns & UC Patients Need to Know DDW 2014 Presentation: 'The impact

It is used in the treatment of neurological conditions caused due to vitamin B1, vitamin B6 and vitamin B12 deficiency

bpc 157 colitis FDA Update: Is It Approved? What Crohns & UC Patients Need to Know DDW 2014 Presentation: 'The impact

[6] In all cases, a healthcare provider should evaluate patient history for any contraindication before initiating therapy

bpc 157 colitis FDA Update: Is It Approved? What Crohns & UC Patients Need to Know DDW 2014 Presentation: 'The impact

Page load link Go to Top

bpc 157 colitis FDA Update: Is It Approved? What Crohns & UC Patients Need to Know DDW 2014 Presentation: 'The impact

Each route has different absorption and research limitations

bpc 157 colitis FDA Update: Is It Approved? What Crohns & UC Patients Need to Know DDW 2014 Presentation: 'The impact
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Home
Home

US$ 28.09

4.8 (12 reviews)

RemedyMeds
RemedyMeds

US$ 21.88

4.1 (11 reviews)

recommand products